Slot machine-maker PlayAGS made its public debut on the New York Stock Exchange Friday, and CEO David Lopez sees opportunity for growth both in the U.S. and abroad. “We’re actually entering the Philippines in the Latin bingo space right now,” he told Cheddar. “That’s about a 70,000-unit market...Then in Brazil...if a new law goes into effect you’ll see 500,000 or so video bingo machines come online.” The company, which primarily serves the Native American Market, brought in revenues of $154 million in the first nine months of 2017 and swung to a profit of $13.6 million for that period. And though the gaming industry has come under pressure from the rise of online and mobile gambling, Lopez says he’s not worried about his casino games getting poached. “It’s a little bit of a training ground for brick and mortar...If you talk about millennials you think, ‘Hey, when are those millenials going to walk into those casinos and start gambling?’ Well some of it starts on their phone.” PlayAGS, backed by private equity firm Apollo Investment, sold 10.3 million shares at $16 apiece in its IPO, valuing it at the low end of its expected range at about $550 million. The stock, which trades under the ticker “AGS”, rose more than 15 percent in its first day of trading. For full interview [click here](https://cheddar.com/videos/playags-rings-nyse-opening-bell-to-celebrate-ipo).

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More